Optimising cellular pathology with cutting-edge artificial intelligence
Histofy is devoted to the development of world-leading AI algorithms for advanced tissue image analytics that can be seamlessly integrated into existing workflows. Our technology enables pathologists to increase the accuracy and efficiency of reporting, ultimately leading to better patient care.
Histofy Values
Adaptability
We are relentless in the pursuit of better patient care, embracing change and swiftly adjusting to new challenges, ensuring our team seizes new opportunities and thrives in a dynamic environment.
Transparency
We act with honesty, integrity and accountability, building trust within our team and with our stakeholders.
Patient Focus
We prioritise patients, making their wellbeing and needs the primary focus of our efforts, guiding our decisions and innovation.
Empowerment
We foster creativity and personal growth, encouraging leadership and providing the tools and environment for our valued team members to achieve success.
Togetherness
The Team
Our founding team have accumulated over 50 years of experience in the field of digital and computational pathology and have now come together to help revolutionise the face of pathology.
Nasir Rajpoot, PhD
Co-Founder, CEO & CSO
With over twenty years’ experience as a global leader in computational pathology, Nasir is responsible for providing leadership to our team and formulating our scientific and commercial strategy.
David Snead, FRCPath
Co-Founder, CMO
A renowned expert in cellular pathology, David has devoted the past thirty years to honing his craft. David oversees the development of Histofy’s products and leads on their implementation into practice.
Simon Graham, PhD
Co-Founder, CTO
With a background in mathematics and computer science, Simon has dedicated the past nine years to developing AI for pathology. Simon leads the transformation of AI research into tangible products.
Chien-Hui Liao, PhD
CFO
Chien has over a decade of experience in the financial sector, having taught in a number of universities and completing an MBA in financial management. Chien leads on our financial strategy and operations.
Adnan Khan, PhD
Principal AI Architect
With over a decade of experience in deploying AI systems, Adnan combines his expertise in product development and computational pathology to create impactful AI solutions for clinical applications.
Dang Vu, PhD
Senior AI Architect
Dang has amassed eight years’ experience as a researcher in computational pathology and machine learning. Dang plays an integral role in the research and productisation of our AI algorithms.
Mostafa Jahanifar, PhD
Senior AI Scientist & Engineer
Mostafa has over 10 years of experience in machine learning and medical imaging. Focussing on generative AI and foundation models, Mostafa helps translate cutting-edge research into real-world solutions.
Simon Tandi
System Administrator
Simon brings over 25 years of IT experience, specialising in Unix system administration, backup, and recovery. He focuses on streamlining processes and supporting customers through installations and upgrades to ensure stable, reliable systems.
Scientific Advisory Board
Prof Mark
Arends
Oncology
Head of Pathology, University of Edinburgh
Dr Naresh
Chachlani
Pathology
Consultant Histopathologist and Founder, DIGIPATH Ltd
Dr Richard
Haworth
Tox. Pathology
Founder and Director, RosettaPath Ltd
Prof Ali
Khurram
Pathology
Head of NeoPath Group, University of Sheffield
Prof Sabine
Tejpar
Oncology
Head of Digestive Oncology, KU Leuven
Dr Jonathan
Williams
Vet. Pathology
Head of Pathology, Royal Veterinary College
Partners and Collaborations
